For the quarter ending 2025-09-30, NYT had $51,599K increase in cash & cash equivalents over the period. $199,730K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Gain from joint ventures | - | - | - | 0 |
| Gain on the sale of land | - | - | - | 0 |
| Net income | 81,647 | 82,945 | -120,549 | - |
| Depreciation and amortization | 21,341 | 21,396 | 21,378 | 21,071 |
| Amortization of right-of-use asset | 2,524 | 2,336 | 2,329 | 2,315 |
| Stock-based compensation expense | 18,507 | 17,803 | 17,353 | 17,619 |
| Impairment charges | - | - | - | 0 |
| Multiemployer pension plan liability adjustment | 0 | 0 | -4,453 | 2,980 |
| Change in long-term retirement benefit obligations | -3,094 | -2,591 | -2,472 | -6,941 |
| Net income | - | - | - | 293,825 |
| Contingent consideration fair value adjustment | -1,471 | - | - | - |
| Other net | 2,394 | -1,562 | 2,629 | -2,953 |
| Accounts receivable net | -6,989 | 18,564 | -57,016 | 60,583 |
| Other assets | -7,385 | 2,808 | -32,079 | 4,632 |
| Accounts payable, accrued payroll and other liabilities | 61,289 | 16,923 | -92,257 | 56,063 |
| Unexpired subscriptions | 7,928 | -3,693 | 6,623 | 9,867 |
| Fair market value adjustment on life insurance products | - | - | - | 1,923 |
| Other noncurrent assets and liabilities | -1,875 | -1,453 | -406 | -1,342 |
| Net cash provided by operating activities | 207,608 | 113,638 | 99,088 | 151,696 |
| Purchases of marketable securities | 173,028 | 132,095 | 168,265 | 142,868 |
| Maturities of marketable securities | 78,392 | 98,374 | 161,931 | 31,128 |
| Capital expenditures | 7,878 | 10,336 | 9,237 | 8,058 |
| Business acquisitions | - | - | - | 0 |
| Other net | -5,479 | -315 | -7,231 | -11,213 |
| (purchases of)/proceeds from investments | - | - | - | 42 |
| Net cash used in investing activities | -97,035 | -43,742 | -8,340 | -108,627 |
| Dividends paid | 29,403 | 29,601 | 22,069 | 21,355 |
| Stock issuances | - | - | - | 0 |
| Payment of contingent consideration | 431 | 0 | - | 1,293 |
| Purchase of noncontrolling interest | - | - | - | 0 |
| Repurchases | 27,319 | 23,604 | 58,957 | 24,702 |
| Share-based compensation tax withholding | 1,821 | 1,277 | 26,243 | 724 |
| Net cash used in financing activities | -58,974 | -54,482 | -107,269 | -48,074 |
| Net decrease in cash, cash equivalents and restricted cash | 51,599 | 15,414 | -16,521 | -5,005 |
| Effect of exchange rate changes on cash | -140 | - | - | - |
| Cash and cash equivalents at beginning of period | 213,857 | - | - | - |
| Cash and cash equivalents at end of period | 264,209 | - | - | - |
NEW YORK TIMES CO (NYT)
NEW YORK TIMES CO (NYT)